Christopher Hinckley

Head, Cellular Models & Molecular Biology Biogen

Seminars

Thursday 30th April 2026
Advancing Target Identification & Validation Using Complex 3D Models to Overcome Animal Model Limitations
3:30 pm
  • Establishing 3D model systems for target translatability to address gaps where animal models lack relevant therapeutic targets
  • Contrasting 2D versus 3D model capabilities to demonstrate complex system advantages and secure essential leadership investment support
  • Implementing rapid model qualification workflows in fast-paced biopharma environments to accelerate target validation and therapeutic development timelines
Christopher Hinckley, Scientific Director, Biogen